A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant HIV. For a small but important group of people living with HIV, treatment has never reached the “one pill a day” milestone. Drug resistance built up over decades, along with other medical conditions and long medication lists, can […] Read More
Check Also
Semaglutide Shows Surprising Mental Health Benefits in Massive 100,000-Person Study
A large-scale study suggests that GLP-1 drugs could have unexpected mental health benefits, including lower …
Newscenter Media News